This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Atopix Therapeutics Limited, Oxagen Limited. Active years: 2010-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2015
Title: Frank Schroer: Innovator in CRTH2 Antagonist Compounds
Introduction
Frank Schroer is a notable inventor based in Oxon, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with CRTH2 antagonist activity. With a total of 5 patents to his name, Schroer has established himself as a key figure in his area of expertise.
Latest Patents
Among his latest patents, Schroer has focused on compounds of general formula (II) that exhibit CRTH2 antagonist activity. These innovations are crucial for advancing therapeutic options in various medical conditions.
Career Highlights
Throughout his career, Frank Schroer has worked with prominent companies such as Atopix Therapeutics Limited and Oxagen Limited. His work in these organizations has contributed to the development of groundbreaking pharmaceutical solutions.
Collaborations
Schroer has collaborated with esteemed colleagues, including Richard Edward Armer and Eric Roy Pettipher. These partnerships have fostered a collaborative environment that enhances innovation and research.
Conclusion
Frank Schroer is a distinguished inventor whose work in CRTH2 antagonist compounds has made a significant impact in the pharmaceutical industry. His contributions continue to influence the development of new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile